August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Susana Banerjee: First Approved Therapy for Low Grade Serous Ovarian Cancer
Jul 13, 2025, 11:56

Susana Banerjee: First Approved Therapy for Low Grade Serous Ovarian Cancer

Susana Banerjee, Professor in Women’s Cancers at The Institute of Cancer Research, shared on X:

“Phase 2 RAMP201 (ENGOTov60/GTG-UK/GOG3052) trial leading to FDA accelerated approval avumetinib and defactinib now published in Journal of Clinical Oncology, Verastem Oncology. First approved therapy for low grade serous ovarian cancer. Thanks all.”

Susana Banerjee

Read this insightful article about Ovarian Cancer:

“FDA Grants Accelerated Approval to Avutometinib and Defactinib for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer: RAMP 201 trial results”

Susana Banerjee